Fixed-dose vs. Phenotype-based PrAsugrel Dose to MATCH Therapeutic Zone in Asians With Acute Coronary Syndrome

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
The purpose of this study is to determine whether the fixed-dose (prasugrel 10 mg/d vs. 5 mg/d) vs. phenotype (platlet function test by VerifyNow P2Y12 assay)-based prasugrel dose adjustment can match therapeutic zone of platelet reactivity in PCI-treated Asians with acute coronary syndrome
Epistemonikos ID: 41138c6fecf18e6ad56e3fa57eab36bf0aa7f411
First added on: May 11, 2024